Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Takeda to Set Up Facility for Gene, Protein Function Analysis
November 19, 2001
- Mitsubishi Research Institute Launches Coding Software Based on Ethical GL
November 19, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 19, 2001
- BUSINESS NEWS IN BRIEF
November 19, 2001
- Greencross-coa: Sales Up 21% to \23.4 Bil.
November 19, 2001
- OBITUARY
November 19, 2001
- DIAGNOSTIC NEWS IN BRIEF
November 19, 2001
- Industry Fights Price Cuts of Original Products: Chuikyo
November 19, 2001
- Cawachi: Half-year Ordinary Profits Remarkably Up 17.8%
November 19, 2001
- 3 NCEs Including Remicade Recommended to Be Approved
November 19, 2001
- Consumers Take Health-Oriented Foods for Better Nutritional Balance: JMARI Survey
November 19, 2001
- BULLETIN
November 19, 2001
- OTC NEWS IN BRIEF
November 19, 2001
- Precautions of 4 Drugs Including Carboplatin Revised Due to ADR
November 19, 2001
- WORLD NEWS IN BRIEF
November 19, 2001
- REGULATORY NEWS IN BRIEF
November 19, 2001
- Sankyo Aims at US Sales of \360 Bil. in FY2010
November 19, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 19, 2001
- Shionogi to Increase Overseas Sales to 10% of Total Sales in 2005
November 19, 2001
- NEW PRODUCTS
November 19, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…